The M367 pill is a high-potency, immediate-release prescription analgesic (painkiller) widely utilized in clinical settings to manage moderate to severe acute pain. Classified as a Schedule II controlled substance in the United States, it carries a high potential for abuse, physical dependence, and psychological addiction.
The M367 tablet is a combination drug, leveraging the synergistic effects of a semi-synthetic opioid and a non-opioid pain reliever to alter how the central nervous system processes pain signals.
Pill Identification
Proper physical identification is vital for patient safety and preventing medication errors. The M367 pill has specific, standardized visual markers:
- Imprint: “M367” is cleanly debossed on one side of the tablet. The “M” represents the manufacturer, Mallinckrodt Pharmaceuticals (though other generic manufacturers distribute it under this formulation imprint).
- Color: Solid white.
- Shape: Capsule-shaped (oblong/oval).
- Scoring: It features a single bisecting score line on the reverse side, allowing the tablet to be split evenly if a doctor prescribes a half-dosage.
- Chemical Classification: Opioid / Non-Opioid Analgesic Combination.
Chemical Composition & Active Ingredients
Every single M367 tablet contains a precise ratio of two distinct active pharmaceutical ingredients:
- Hydrocodone Bitartrate (10 mg): A potent, semi-synthetic opioid agonist derived from codeine.
- Acetaminophen (325 mg): A widely used non-opioid analgesic and antipyretic (fever reducer), commonly known internationally as paracetamol.
Historically, formulations like older versions of Vicodin paired hydrocodone with much higher doses of acetaminophen (e.g., 500 mg or 750 mg). Modern manufacturing standards limit the acetaminophen content to 325 mg per tablet to minimize the risk of severe consumer liver damage.
Mechanism of Action
The M367 pill attacks pain through two completely separate pathways in the body, which makes the combination exceptionally effective:
Hydrocodone
Hydrocodone acts directly on the Central Nervous System (CNS). It binds to specific proteins called opioid receptors (mu-opioid receptors) located in the brain and spinal cord. Once activated, these receptors inhibit the release of nociceptive (pain-signaling) neurotransmitters. Essentially, it doesn’t stop the source of the physical injury, but it fundamentally alters how the brain perceives and emotionally responds to pain, while inducing a wave of relaxation and mild euphoria.
Acetaminophen
While its exact systemic mechanism is still researched, acetaminophen primarily works in the brain by inhibiting cyclooxygenase (COX) enzymes, preventing the formation of prostaglandins—the chemical compounds responsible for sending pain signals and elevating body temperature. When paired together, acetaminophen clinically enhances the pain-relieving efficacy of the hydrocodone.
Dosage and Administration
Dosage must be strictly individualized by a medical provider based on the severity of the pain and the patient’s prior exposure to opioid therapies.
Standard Adult Dosage
- Typical Dose: One tablet every 4 to 6 hours as needed for severe pain.
- Maximum Single Dose: 1 tablet (10 mg hydrocodone / 325 mg acetaminophen).
- Absolute Daily Ceilings
- Acetaminophen limit: A patient must never exceed 4,000 mg of acetaminophen in a 24-hour window from all dietary and medicinal sources.
- M367 specific limit: Patients should typically never exceed 6 tablets within a 24-hour period (which equates to 60 mg of hydrocodone and 1,950 mg of acetaminophen) unless explicitly instructed and monitored by a specialized pain clinician.
Crucial Safety Administration Rules
- Swallow Whole: The immediate-release tablet must be taken orally. Crushing, chewing, snorting, or dissolving the pill bypasses its intended digestion rate and can cause a fatal, immediate overdose.
- Tapering: If a patient has been taking M367 for more than a few days, they must not stop abruptly. The dosage must be gradually tapered downward by a physician to prevent severe physical withdrawal syndrome.
Side Effects
Side effects vary extensively based on individual tolerance, duration of therapy, and metabolic factors.
Common (Mild to Moderate) Side Effects
These symptoms generally occur as the body adjusts to the opioid component and often subside with rest:
- Drowsiness, lethargy, or severe fatigue
- Dizziness and lightheadedness (especially when standing up too quickly)
- Nausea, vomiting, and general upset stomach
- Constipation: Opioids inherently slow down the digestive tract’s motility. Long-term users are frequently prescribed a stool softener alongside M367.
- Dry mouth and increased sweating
- Mild skin itching
Serious (Requires Immediate Emergency Medical Attention)
- Respiratory Depression: Unusually slow, shallow, or labored breathing; long pauses between breaths.
- CNS Depletion: Extreme, un-wakeable sleepiness, confusion, or profound muscle weakness.
- Hypotension: A dangerous drop in blood pressure, causing fainting or a dangerously slow heart rate.
- Serotonin Syndrome: Agitation, hallucinations, rapid heart rate, severe muscle twitching, or shivering (especially when mixed with certain antidepressants).
- Adrenal Insufficiency: Long-term use can damage hormone production, causing chronic nausea, worsening dizziness, and severe fatigue.
Precautions & Contraindications
Before accepting a prescription for M367, patients must undergo a rigorous screening regarding their complete medical history.
Strict Contraindications (Who Should NOT Take It)
- Individuals with severe asthma, chronic obstructive pulmonary disease (COPD), or any acute respiratory issues.
- Anyone experiencing a known or suspected gastrointestinal blockage, such as a paralytic ileus.
- Patients who have taken a Monoamine Oxidase Inhibitor (MAOI) antidepressant (like phenelzine or selegiline) within the past 14 days.
Medical Warnings & Precautions
- Liver Disease: Because acetaminophen is heavily processed by the liver, individuals with compromised hepatic function are at an elevated risk for acute liver failure.
- Head Injuries: Hydrocodone can increase the fluid pressure inside the skull, making it highly dangerous for patients recovering from recent concussions or brain tumors.
- Pregnancy & Breastfeeding: Prolonged use of M367 during pregnancy can cause Neonatal Opioid Withdrawal Syndrome (NOWS), a life-threatening condition where the newborn baby experiences intense opioid withdrawal at birth. The drug also passes directly into breast milk, posing a high risk of fatal respiratory depression in nursing infant
Boxed Warnings & Interaction Dangers
The FDA applies its most severe warnings—Boxed Warnings—to medications containing hydrocodone due to the profound systemic risks involved.
Addiction, Misuse, and Abuse
M367 exposes users to the risks of opioid addiction, which can lead to overdose and death. Even when taken exactly as directed by a healthcare professional, the brain can rapidly develop a chemical tolerance (requiring higher doses to achieve the same pain relief) and physical dependence.
Life-Threatening Respiratory Depression
The most severe threat of an opioid is its tendency to desensitize the brainstem to carbon dioxide, slowing down the automatic drive to breathe. This risk is highest when first starting the medication or following a dose escalation.
Accidental Ingestion
A single accidental dose of M367 taken by a child, pet, or non-tolerant adult can result in fatal respiratory failure. The medication must be kept in a locked, secure location.
Fatal Interaction with Alcohol and Sedatives
Mixing M367 with alcohol, street drugs, or other prescription sedatives—specifically Benzodiazepines (such as Xanax, Valium, or Ativan)—creates a compounding effect on the central nervous system. This combination is one of the leading causes of accidental drug-induced comas and fatal overdoses.
Emergency Countermeasure: Due to the risk of accidental overdose or respiratory depression, clinicians strongly recommend that patients prescribed M367 keep Naloxone (Narcan) easily accessible at home. Naloxone is a life-saving nasal spray that can temporarily reverse the effects of an opioid overdose while emergency medical services are en route.